The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.
There are four major factors that are impacting the value creation in pharmaceutical industry:
Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases
Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.
The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.
Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.
Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.
Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.
Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.
Growth in Emerging Economies
The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.
Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.
There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.
Cutaneous squamous cell carcinoma (cSCC) is a type of non-melanoma skin cancer (NMSC), which is the most frequently diagnosed skin cancer. Most of the cSCCs are localized and easily treatable, and according to the National Center for Biotechnology Information (NCBI), ... Read more
Progressive supranuclear palsy (PSP) is a rare progressive condition that can cause problems with balance, movement, vision, speech, and swallowing. It is caused due to increasing numbers of brain cells getting damaged over time. Progressive supranuclear palsy (PSP) i... Read more
Niemann-Pick disease type C (NPC) belongs to a group of lysosomal storage disorders. The onset of symptoms for NPC may begin at different ages. It has been grouped as: infantile (after birth to less than 6 years), juvenile (6 to 15 years), and adults (15 years to grea... Read more
Health supplementary food is recommended for patients with chronic disease conditions in order to combat the weak immune system, which affects eating habits and results in drastic weight loss. The increasing prevalence of chronic diseases such as diabetes and chronic ... Read more
Acute bacterial skin and skin structure infections (ABSSSI) are the type of skin and soft tissue infections that affect the epidermis, dermis, and subcutaneous tissues. The U.S. FDA defines ABSSSI as lesions with cellulitis/erysipelas, wound infections, and major cuta... Read more
Vaginal fungi infections is identified by various symptoms such as swelling around the vagina, burning sensation during urination or sex, whitish-gray and clumpy vaginal discharge, and many others. Vaginal yeast infection is also known as candidiasis. A healthy vagina... Read more
GM1 Gangliosidosis is an inherited central nervous system disorder that destroys nerve cells in the spinal cord and brain. GM1 gangliosidosis is classified mainly into three types depending upon the signs and symptoms of the disorder. Type 1 GM1 gangliosidosis include... Read more
Community-acquired pneumonia (CAP) refers to pneumonia that is acquired in the community setting, which is caused by various bacterial species, such as S. pneumoniae, Haemophilus influenzae type b (Hib), Chlamydia pneumoniae, Mycoplasma, pneumoniae, or Legionella ... Read more
Softgel capsule are also called as soft gelatin capsules, that have solid (outer shell) and is surrounding with a semi-solid or liquid drug constituent (inner fill). The active pharmaceutical ingredient can be incorporated in the outer shell of gelatin capsule or in t... Read more
Hereditary angioedema (HAE) is an autosomal disorder characterized by low levels of functional C1 esterase inhibitor protein. Purified concentrate of C1 esterase inhibitors are used in HAE affected patients for the prophylactic and acute attack treatment of HAE. Sever... Read more
Herceptin is a monoclonal antibody used to treat patients suffering from metastatic (spread) breast cancer and gastric cancers. Hereceptin is used as part of chemotherapy regimen for adjuvant treatment of lymph-node positive, HER2/neu protein positive breast cancer. H... Read more
Pediatric palliative care is a specialized medical care for infants and children living with serious medical conditions such as cancer, genetic disorders, prematurity, heart and lung conditions, neurologic disorders, and others. The goal of palliative care is to impro... Read more
Interferons are a family of naturally occurring proteins that are produced by eukaryotic cells and mostly show action against viral infections and other biological inducers. There are three major forms of interferons that have been distinguished as alpha, beta, and ga... Read more
Benzocaine is also known as americaine or anaesthesin and belongs to the class of organic compounds known as benzoic acid esters. Benzocaine is an active pharmaceutical ingredient having various medicinal properties. It is used as sexual disorders such as premature ej... Read more
Reperfusion injury is caused due to the damage in the tissue, which occurs due to the lack of blood supply. Examples of reperfusion injury include brain damage after stroke and many others, where reperfusion therapy leads to flow of blood in the tissue which results i... Read more
BRAF is a kinase enzyme that helps control cell growth and signaling. It may be found in a mutated (changed) form in some types of cancer, including melanoma and colorectal cancer. Blocking mutated BRAF kinase proteins helps to stop the cancer cells from growing. Some... Read more
Buprenorphine plays a major role in advanced healthcare as it is used in acute pain management, chronic pain management and in treatment of opioid addiction. It is synthetic phenanthrene with narcotic analgesic activity. The global... Read more
The drug, amitriptyline, is a tricyclic antidepressants used in the treatment of various health conditions such as chronic neuropathic pain, depression, and others. The drug is also used off-label in treatment of migraine. Amitriptyline affects certain chemical messen... Read more